Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -41.68%509.4M | -23.22%873.5M | 22.86%1.14B | 1.31%926M | 2.83%914.01M | 4.18%888.89M | 8.91%853.19M | 87.91%783.42M | -5.56%416.92M | -16.35%441.48M |
| Revenue from customers | -44.28%509.2M | -20.53%913.9M | 23.11%1.15B | 1.66%934.1M | 3.37%918.88M | 5.61%888.89M | 7.44%841.68M | 88.15%783.4M | -5.65%416.38M | -16.33%441.32M |
| Other cash income from operating activities | 100.50%200K | -228.46%-40.4M | -51.85%-12.3M | -66.53%-8.1M | ---4.86M | ---- | 41,000.00%11.51M | -94.81%28K | 231.29%540K | -49.85%163K |
| Cash paid | 38.88%-509.1M | -20.89%-832.9M | -57.16%-689M | 5.05%-438.4M | 6.42%-461.72M | -2.72%-493.38M | 3.62%-480.32M | -45.97%-498.38M | -0.14%-341.44M | -4.48%-340.96M |
| Payments to suppliers for goods and services | 39.40%-447.1M | -25.18%-737.8M | -57.64%-589.4M | 6.03%-373.9M | 5.88%-397.91M | 0.80%-422.78M | 6.87%-426.19M | -41.51%-457.65M | -0.78%-323.42M | -6.76%-320.93M |
| Other cash payments from operating activities | 34.81%-62M | 4.52%-95.1M | -54.42%-99.6M | -1.08%-64.5M | 9.61%-63.81M | -30.43%-70.59M | -32.89%-54.12M | -126.00%-40.73M | 10.03%-18.02M | 22.18%-20.03M |
| Direct dividend received | ---- | -35.71%761.4M | 1,575.25%1.18B | --70.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| Direct interest paid | 47.83%-7.2M | 58.81%-13.8M | -679.07%-33.5M | 50.42%-4.3M | -164.47%-8.67M | 27.74%-3.28M | 42.53%-4.54M | ---7.9M | ---- | -556.07%-6.92M |
| Direct interest received | -18.72%15.2M | 125.30%18.7M | 295.24%8.3M | -13.65%2.1M | -53.97%2.43M | 33.00%5.28M | 502.88%3.97M | -70.06%659K | 38.69%2.2M | 17.47%1.59M |
| Direct tax refund paid | -46.85%34.6M | 135.23%65.1M | 7.14%-184.8M | ---199M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating cash flow | -95.08%42.9M | -38.73%872M | 298.52%1.42B | -19.94%357.1M | 12.21%446.05M | 6.77%397.52M | 34.02%372.31M | 257.64%277.81M | -18.40%77.68M | -52.81%95.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 98.34%-4M | 18.15%-240.3M | 77.08%-293.6M | -20.28%-1.28B | -823.30%-1.06B | -39.28%-115.34M | 21.13%-82.81M | 61.58%-105M | 35.47%-273.29M | -393.07%-423.48M |
| Capital expenditure reported | 97.44%-4.7M | 42.01%-183.3M | -355.48%-316.1M | 13.79%-69.4M | -13.99%-80.5M | 21.37%-70.62M | 24.97%-89.81M | 46.60%-119.7M | 0.85%-224.14M | -299.89%-226.08M |
| Net PPE purchase and sale | 112.18%1.9M | 30.04%-15.6M | -19.89%-22.3M | -31.53%-18.6M | -238.69%-14.14M | -25.29%10.2M | 167.23%13.65M | -67.13%-20.3M | -294.34%-12.15M | 138.42%6.25M |
| Net business purchase and sale | ---- | ---- | ---- | -19.60%-1.17B | ---977M | ---- | ---- | ---- | 91.30%-17.57M | ---202.05M |
| Net investment purchase and sale | 99.76%-100K | -191.96%-41.2M | 1,700.00%44.8M | -141.61%-2.8M | 106.13%6.73M | -725.63%-109.84M | -49.16%-13.3M | -48.80%-8.92M | -273.46%-5.99M | 87.73%-1.61M |
| Net other investing changes | -450.00%-1.1M | ---200K | ---- | -36,679.66%-21.7M | -100.37%-59K | -41.03%15.78M | -39.05%26.76M | 426.96%43.91M | ---13.43M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 98.34%-4M | 18.15%-240.3M | 77.08%-293.6M | -20.28%-1.28B | -823.30%-1.06B | -39.28%-115.34M | 21.13%-82.81M | 61.58%-105M | 35.47%-273.29M | -393.07%-423.48M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 76.33%-223.4M | -29.86%-943.7M | -195.39%-726.7M | 20.35%761.8M | 641.21%633M | -44.82%-116.96M | -17.25%-80.76M | -137.16%-68.88M | -26.56%185.33M | 563.82%252.35M |
| Net issuance payments of debt | ---- | 33.36%-360M | -160.70%-540.2M | 1,291.87%889.9M | -161.33%-74.66M | 50.00%-28.57M | 0.00%-57.14M | 19.52%-57.14M | -126.20%-71M | 1,184.00%271M |
| Net common stock issuance | ---- | ---- | ---- | ---- | --749.1M | ---- | ---- | ---- | --273.93M | ---- |
| Cash dividends paid | 63.38%-196.9M | -273.66%-537.7M | -26.67%-143.9M | -284.56%-113.6M | 64.29%-29.54M | -250.19%-82.71M | -101.25%-23.62M | 33.32%-11.74M | -37.66%-17.6M | 50.38%-12.79M |
| Net other financing activities | 66.41%-26.5M | -9.43%-78.9M | -281.48%-72.1M | -4.84%-18.9M | -58.81%-18.03M | ---11.35M | ---- | ---- | ---- | 10.66%-6.38M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 76.33%-223.4M | -29.86%-943.7M | -195.39%-726.7M | 20.35%761.8M | 641.21%633M | -44.82%-116.96M | -17.25%-80.76M | -137.16%-68.88M | -26.56%185.33M | 563.82%252.35M |
| Net cash flow | ||||||||||
| Beginning cash position | -39.63%468M | 111.17%775.2M | -30.54%367.1M | 3.56%528.5M | 46.55%510.31M | 151.07%348.21M | 287.80%138.69M | -22.70%35.76M | -61.86%46.26M | 112.90%121.3M |
| Current changes in cash | 40.87%-184.5M | -177.46%-312M | 348.49%402.8M | -1,251.52%-162.1M | -91.48%14.08M | -20.85%165.21M | 100.85%208.74M | 1,111.13%103.92M | 86.47%-10.28M | -223.64%-75.94M |
| Effect of exchange rate changes | -179.17%-3.8M | -9.43%4.8M | 657.14%5.3M | -83.03%700K | 232.64%4.13M | -496.68%-3.11M | 178.48%784K | -347.98%-999K | -124.59%-223K | -68.77%907K |
| End cash Position | -40.24%279.7M | -39.63%468M | 111.17%775.2M | -30.54%367.1M | 3.57%528.51M | 46.55%510.31M | 151.07%348.21M | 287.80%138.69M | -22.70%35.76M | -61.86%46.26M |
| Free cash from | -94.41%37.6M | -37.95%673.1M | 303.23%1.08B | -23.44%269M | 13.39%351.34M | 16.43%309.85M | 93.39%266.12M | 185.46%137.61M | -13.73%-161.03M | -210.12%-141.59M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |